Asano et al. examined the possible prognostic role of L1CAM in 161 patients with endometrial cancer undergoing surgery and adjuvant chemotherapy; they found L1CAM expression (tissue microarrays, clone 14.10, dilution 1:50, H-score with the cutoff set at 35) in almost 30% of the cases [76]. This evidence concerns the gene L1CAM and endometrial cancer.